PELIAS

Welcome to the Brand page for “PELIAS”, which is offered here for Pharmaceuticals, drug delivery systems incorporating pharmaceutical drugs and polymer-based hydrogels for the sustained release delivery of protein, small molecule and peptide drugs;product research and development for others in the field of pharmaceuticals, sustained release drug delivery systems applied to proprietary or generic proteins, peptides or small molecules;.

Its status is currently believed to be active. Its class is unavailable. “PELIAS” is believed to be currently owned by “Infimed Therapeutics, Inc.”